HER3 antibodies and uses thereof
US9637543B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 9, 2012 |
| Grant date | May 2, 2017 |
| Priority date | — |
| Expiry date | Nov 9, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are antibodies specific for HER3. Also provided are methods of treating cancer in a subject comprising administering an effective amount of the antibodies described herein to the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.